Cornell Research Foundation, Inc.;Clinical Research Institute of Montreal
发明人:
Szeto, Hazel H.,Zhao, Kesheng,Schiller, Peter W.
申请号：
HUE13178043
公开号：
HUE027110T2
申请日:
2004.02.03
申请国别(地区):
HU
年份:
2016
代理人:
摘要：
The invention provides a method of reducing or preventing mitochondrial permeability transitioning. The method comprises administering an effective amount of an aromatic-cationic peptide having at least one net positive charge； a minimum of four amino acids； a maximum of about twenty amino acids； a relationship between the minimum number of net positive charges (p m ) and the total number of amino acid residues (r) wherein 3p m is the largest number that is less than or equal to r + 1； and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (p t ) wherein 2a is the largest number that is less than or equal to p t + 1, except that when a is 1, p t may also be 1.
